Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Oct 03, 2018 1:23pm
139 Views
Post# 28738662

When will good news out weigh the no news?

When will good news out weigh the no news?or when will good news out weigh the bad news?  Each day I get up and look at the SP and each day is a sinking feeling.  The mood over PLI is always sh-t on a stick.  News that was projected to arrive by a certain date never arrives, instead we get either no news or bad news.  An example was the anticipated approval of Ryplazim last April we got bad news.  We expected news of the mid sept meeting on quality control, now we sit and wait for the news, the minutes or whatever.  There is always an excuse.  This has been the pattern for a long time.  PLI builds up the anticipation and then dissapoints.  There is a stain on this company and it is growing daily.

I think that if they cant get credible results on their CMS for the production of plasminogen and Ryplazim by the end of the year then we should make a concerted effort to oust the CEO and the CFO.  The shareholders have paid a heavy price for mediocrity.


Bullboard Posts